HomePortfolios10 year plan (available)

10 year plan (available)

10 year plan

Optimize
None Rebalancing
EUR
Moderate Risk
2.2yr backtest

Performance Summary

Total Return+36.56%
Annualized Return+15.45%
Volatility+13.48%
Sharpe Ratio1.00
Max Drawdown+19.21%

Holdings

Asset Allocation

Asset Class

Equity 100.0%
Holdings Details
Long-term global ETF portfolio with US, European, and emerging markets exposure for diversified growth over a decade.
AssetTypeAllocationTER
EXUS.XETRA
Xtrackers MSCI World ex USA UCITS ETF 1CIE0006WW1TQ4
ETF
30.0%0.15%
ZA30.XETRA
iShares S&P 500 Scored and Screened UCITS ETF USD (Acc)IE000R9FA4A0
ETF
30.0%0.07%
IS3N.XETRA
iShares Core MSCI Emerging Markets IMI UCITSIE00BKM4GZ66
ETF
15.0%0.18%
EUNK.XETRA
iShares Core MSCI Europe UCITS ETF EUR (Acc)IE00B4K48X80
ETF
15.0%0.12%
IUSN.XETRA
iShares MSCI World Small Cap UCITS ETFIE00BF4RFH31
ETF
10.0%0.35%
Total100.0%0.15%

Performance

Portfolio Value Over Time
Starting with 10,000 investment → now worth €13,655.68
Histogram of Monthly Returns
The portfolio had a positive return during 19 of the 27 months (70%)
Monthly Returns Heatmap
Best month: +7.9% • Worst month: -6.7% • Best year: 2025 (+13.0%) • Worst year: 2026 (+9.4%)
YearJanFebMarAprMayJunJulAugSepOctNovDecTotal
2026+2.8%+3.4%-6.7%+7.9%+2.2%-------+9.4%
2025+4.3%-0.8%-5.7%-3.3%+5.4%+0.7%+3.6%+0.6%+2.6%+4.0%+0.1%+1.3%+13.0%
2024--+2.6%-1.3%+1.6%+2.7%+1.0%-0.3%+1.5%-0.7%+4.8%-1.6%+10.5%
> +2%
0% to +2%
-2% to 0%
< -2%
Drawdown Analysis
Maximum drawdown: +19.21% • The longest drawdown period lasted for 6 months and was between February 2025 and September 2025. It reached a trough of -19.2%.

Detailed Metrics

Returns
Total Return
+36.56%
Annualized Return
+15.45%
Avg Monthly Return
+1.21%
Risk
Volatility (Annual)
+13.48%
Max Drawdown
+19.21%
Positive Months
70%
Average Drawdown
-2.8%
Risk-Adjusted
Sharpe Ratio
1.00
Risk-free rate: 2.0%
Sortino Ratio
0.94
Downside risk adjusted
Return/Volatility
1.15
Calmar Ratio
0.80
Return/Max Drawdown
Ulcer Index
3.82
Drawdown depth & duration
Martin Ratio
0.04
Return/Ulcer Index
Backtest Configuration
Initial Investment
10,000
Final Value
13,655.68
Backtest Period
2024-03-14 to 2026-05-15
2.2 years
Rebalancing
none
Base Currency
EUR